Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck

被引:0
|
作者
Anna-Maria A. De Costa
Corinne A. Schuyler
David D. Walker
M. Rita I. Young
机构
[1] Ralph H. Johnson Veterans Affairs Medical Center,Research Service (151)
[2] Medical University of South Carolina,Department of Otolaryngology, Head and Neck Surgery
[3] Medical University of South Carolina,Department of Medicine
来源
Cancer Immunology, Immunotherapy | 2012年 / 61卷
关键词
HNSCC; Premalignant; Immunoediting; Th1/Tc1 cells; Th17 cells;
D O I
暂无
中图分类号
学科分类号
摘要
While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes of HNSCC-bearing mice were found to contain a greater number of cells, including a greater number of conventional (Tconv) and regulatory (Treg) T cells, compared to cervical lymph nodes of control and premalignant lesion-bearing mice, though the Tconv cells appear to be less proliferative and the Treg cells appear to be less suppressive at the HNSCC stage. Premalignant lesion-bearing mouse lymph nodes consist of a greater percentage of Tconv cells expressing markers for activation, memory, and exhaustion compared to both control and HNSCC-bearing mice. Also, lymph nodes’ cells from both premalignant lesion-bearing and HNSCC-bearing mice include increased levels of Th1, Tc1, and Th17 cells, with no differences in levels of Th2 cells, compared to control mice. The data show that while there is the expected increase in immunosuppressive Tregs in lymph nodes when HNSCC is present, there is also an unexpected increase in immune populations usually associated with a beneficial antitumor response, including Tconv cells and Th1 and Tc1 cells. In addition, the results demonstrate that the premalignant stage of HNSCC development is associated with a robust immune response involving an increase in inflammatory Th1, Tc1, and Th17 cells.
引用
收藏
页码:927 / 939
页数:12
相关论文
共 50 条
  • [31] Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
    Bauer, Verena L.
    Hieber, Ludwig
    Schaeffner, Quirin
    Weber, Johannes
    Braselmann, Herbert
    Huber, Reinhard
    Walch, Axel
    Zitzelsberger, Horst
    GENES, 2010, 1 (03) : 388 - 412
  • [32] Changes in Protein Glycosylation in Head and Neck Squamous Cell Carcinoma
    Liao, Chengcheng
    An, Jiaxing
    Tan, Zhangxue
    Xu, Fangping
    Liu, Jianguo
    Wang, Qian
    JOURNAL OF CANCER, 2021, 12 (05): : 1455 - 1466
  • [33] Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma
    Lehnerdt, G.
    Hoffmann, T. K.
    Mattheis, S.
    Brandau, S.
    Zeidler, R.
    Lang, S.
    HNO, 2010, 58 (07) : 713 - 725
  • [34] Targeted therapy for head and neck squamous cell carcinoma microenvironment
    Guo, Zhaomeng
    Li, Kang
    Liu, Peng
    Zhang, Xiangmin
    Lv, Jie
    Zeng, Xianhai
    Zhang, Peng
    FRONTIERS IN MEDICINE, 2023, 10
  • [35] EGFR inhibition as a therapy for head and neck squamous cell carcinoma
    Loeffler-Ragg, Judith
    Schwentner, Ilona
    Sprinzl, Georg M.
    Zwierzina, Heinz
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (10) : 1517 - 1531
  • [36] Centrosome abnormalities in head and neck squamous cell carcinoma (HNSCC)
    Reiter, Rudolf
    Gais, Peter
    Steuer-Vogt, Miriam K.
    Boulesteix, Anne-Laure
    Deutschle, Tom
    Hampel, Regina
    Wagenpfeil, Stefan
    Rauser, Sandra
    Walch, Axel
    Bink, Karin
    Juetting, Uta
    Neff, Frauke
    Arnold, Wolfgang
    Hoefler, Heinz
    Pickhard, Anja
    ACTA OTO-LARYNGOLOGICA, 2009, 129 (02) : 205 - 213
  • [37] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Genomics and precision surgery for head and neck squamous cell carcinoma
    Galmiche, Antoine
    Saidak, Zuzana
    Bouaoud, Jebrane
    Mirghani, Haitham
    Page, Cyril
    Dakpe, Stephanie
    Clatot, Florian
    CANCER LETTERS, 2020, 481 : 45 - 54
  • [39] Immunotherapy for HPV negative head and neck squamous cell carcinoma
    Jiang, Binyumeng
    Elkashif, Ahmed
    Coulter, Jonathan A.
    Dunne, Nicholas J.
    Mccarthy, Helen O.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):
  • [40] Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma
    Jumaniyazova, Enar
    Lokhonina, Anastasiya
    Dzhalilova, Dzhuliia
    Kosyreva, Anna
    Fatkhudinov, Timur
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):